To identify whether IDH mutations are primary or subclonal, we screened 54 samples harboring IDH active‐site mutations detected in tissues and compared the levels of variant allele frequencies (VAFs) between IDH mutants and other important trunk driver genes in NSCLC (Figure 4A). Here, IDH2 is linked to non-small cell lung carcinoma.